Polymerase chain reaction detection of Chlamydia pneumoniae in circulating white blood cells

Research output: Contribution to journalArticlepeer-review

Abstract

Several recently published studies suggest that Chlamydia pneumoniae may represent a risk factor for atherosclerosis or its complications. In order to establish whether C. pneumoniae is causally linked to atherosclerotic diseases, clinical intervention trials may be needed. However, to identify eligible subjects with a persistent C. pneumoniae infection and to monitor the effect of antibiotic therapy, there is a need for a reliable diagnostic marker. Blood-based polymerase chain reaction assays may be of value for identifying patients persistently infected with C. pneumoniae and for assessing the microbiologic efficacy of antichlamydial therapy in clinical intervention trials.

Original languageEnglish (US)
Pages (from-to)S452-S454
JournalJournal of Infectious Diseases
Volume181
Issue number6 SUPPL. 3
DOIs
StatePublished - 2000

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Polymerase chain reaction detection of Chlamydia pneumoniae in circulating white blood cells'. Together they form a unique fingerprint.

Cite this